Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 50.08
-0.62 (-1.22%)
At close: Feb 13, 2026
Acrobiosystems Market Cap
Acrobiosystems has a market cap or net worth of 8.35 billion as of February 13, 2026. Its market cap has increased by 42.47% in one year.
Market Cap
8.35B
Enterprise Value
6.54B
Revenue
794.52M
Ranking
n/a
PE Ratio
48.66
Stock Price
50.08
Market Cap Chart
Since October 18, 2021, Acrobiosystems's market cap has decreased from 13.51B to 8.35B, a decrease of -38.18%. That is a compound annual growth rate of -10.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 8.38B | -7.26% |
| Dec 31, 2025 | 9.04B | 71.05% |
| Dec 31, 2024 | 5.28B | -25.26% |
| Dec 29, 2023 | 7.07B | -13.93% |
| Dec 30, 2022 | 8.22B | -51.36% |
| Dec 31, 2021 | 16.89B | 25.06% |
| Oct 18, 2021 | 13.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 9.28B |
| Daan Gene | 9.14B |
| Sino Biological,Inc. | 9.04B |
| Shanghai Medicilon | 8.97B |
| Anhui Huaheng Biotechnology | 8.83B |
| Jiangxi Fushine Pharmaceutical | 8.62B |
| Nanjing Vazyme Biotech | 8.35B |
| Zhejiang Ausun Pharmaceutical | 8.18B |